FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18194211000001101: Supralip 160mg tablets (Necessity Supplies Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62434401000001114 Supralip 160mg tablets (Necessity Supplies Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62434501000001113 Supralip 160mg tablets (Necessity Supplies Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Supralip 160mg tablets (Necessity Supplies Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Is a Product containing precisely fenofibrate micronized 160 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Has active ingredient Fenofibrate micronized false Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Has specific active ingredient Fenofibrate micronized true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Is a Supralip true Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Supralip 160mg tablets (Necessity Supplies Ltd) 28 tablet Has AMP True Supralip 160mg tablets (Necessity Supplies Ltd) Inferred relationship Existential restriction modifier
Supralip 160mg tablets (Necessity Supplies Ltd) 30 tablet Has AMP True Supralip 160mg tablets (Necessity Supplies Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start